Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Goodgrower is a private investment firm focused exclusively on the healthcare sector rather than a drug-development biotech or pharmaceutical company. It is the healthcare investment vehicle of the Gallardo Family Group and invests in both public and private companies, primarily across the non-pharma and non-biotech healthcare value chain. The firm provides capital as well as sector expertise and operational support to management teams. Its focus appears to include healthcare services, care delivery, and related healthcare businesses in Europe and the United States. For a biotech analyst, Goodgrower is best understood as a healthcare-focused investor and owner/operator-backed investment platform, not a therapeutics developer with an R&D pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Goodgrower.